Ping-kuen Lam. / "May 1998." / Thesis (Ph.D.)--Chinese University of Hong Kong, 1998. / Includes bibliographical references (p. 109-121). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.

by Henry Yurianto. / "18 September 1998." / Thesis (Ph.D.)--Chinese University of Hong Kong, 1998. / Includes bibliographical references (p. 138-149). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web.

Thesis (Ph. D.)--University of Virginia, 2007. / Includes bibliographical references. Also available online through Digital Dissertations.

Diss. (sammanfattning) Göteborg : Univ. , 2008. / Härtill 4 uppsatser.

Diss. Stockholm : Karolinska institutet, 2006.

O autor estudou comparativamente, em coelhos, enxertos autólogos retirados do crânio e da crista ilíaca. Os animais foram divididos em dois lotes, crânio e crista ilíaca e a seguir distribuídos em três grupos diferentes, de acordo com o tempo de incorporação do enxerto ósseo. Foram correlacionados as medidas das dimensões e peso do enxerto com os achados histológicos realizados após o sacrifício do animal. O autor observou que o enxerto autólogo de crista ilíaca apresentou maior reabsorção que o de crânio aos sessenta dias. O enxerto autólogo de crânio iniciou a formação óssea mais precocemente que o enxerto de crista ilíaca / The author compared cranial and iliac crest autogenous bone grafts using an experimental model in rabbits. 57 animals were studied and divided in three different groups, according with the time of evaluation, of the bone graft, 18, 30 and 60 days after the first procedure. Before being positioned on the nasal bone and fixed with a screw, the bone grafts were measured and weighted. The same measures were done at the time of removal of the bone graft and all these datas were correlated with the information achieved with histomorphometric parameters of osteogenesis (bone volume, osteoid volume, osteoid surface, osteoblastic surface and osteoid thickness) and of bone resorption (osteoclastic surface and resorption surface). The author concluded: the relation final wight/inicial weight in the cranial bone grafts was greater than in the iliac crest bone grafts; the osteogenesis was smaller on the 18th day in the iliac crest bone grafts group than the control group; the osteogenesis was greater in the cranial bone grafts group than the iliac crest bone grafts group on the 18th and 30th day after bone grafting; the bone resorption was greater in the iliac crest bone grafts group than the cranial bone grafts group after 60 days; the presence of superficial osteogenesis was increased in the cranial bone grafts.

O autor estudou comparativamente, em coelhos, enxertos autólogos retirados do crânio e da crista ilíaca. Os animais foram divididos em dois lotes, crânio e crista ilíaca e a seguir distribuídos em três grupos diferentes, de acordo com o tempo de incorporação do enxerto ósseo. Foram correlacionados as medidas das dimensões e peso do enxerto com os achados histológicos realizados após o sacrifício do animal. O autor observou que o enxerto autólogo de crista ilíaca apresentou maior reabsorção que o de crânio aos sessenta dias. O enxerto autólogo de crânio iniciou a formação óssea mais precocemente que o enxerto de crista ilíaca / The author compared cranial and iliac crest autogenous bone grafts using an experimental model in rabbits. 57 animals were studied and divided in three different groups, according with the time of evaluation, of the bone graft, 18, 30 and 60 days after the first procedure. Before being positioned on the nasal bone and fixed with a screw, the bone grafts were measured and weighted. The same measures were done at the time of removal of the bone graft and all these datas were correlated with the information achieved with histomorphometric parameters of osteogenesis (bone volume, osteoid volume, osteoid surface, osteoblastic surface and osteoid thickness) and of bone resorption (osteoclastic surface and resorption surface). The author concluded: the relation final wight/inicial weight in the cranial bone grafts was greater than in the iliac crest bone grafts; the osteogenesis was smaller on the 18th day in the iliac crest bone grafts group than the control group; the osteogenesis was greater in the cranial bone grafts group than the iliac crest bone grafts group on the 18th and 30th day after bone grafting; the bone resorption was greater in the iliac crest bone grafts group than the cranial bone grafts group after 60 days; the presence of superficial osteogenesis was increased in the cranial bone grafts.

Foram analisados 106 pacientes portadores de Linfoma de Hodgkin (LH) com recidiva da doença ou refratários ao tratamento inicial que foram submetidos ao transplante autólogo de células tronco hematopoiéticas (TCTH), na ordem consecutiva de sua realização, entre o mês de abril de 1993 a dezembro de 2007 em um único Centro Brasileiro: o Serviço de Transplante de Medula Óssea da FMUSP. O grupo teve a mediana etária de 28 anos, 55 pacientes (51,9%) eram do sexo masculino e houve predomínio da raça branca (87,6%). A mediana de seguimento clínico foi de 56,4 meses. Todos pacientes foram submetidos no pré TCTH a protocolos de tratamento convencionais, sendo que o uso dos protocolos MOPP, ABVD e sua associação foram utilizados em 97 pacientes (91,5%). Os pacientes foram classificados, de acordo com a resposta ao tratamento utilizado antes do TCTH, sendo 38,1% considerados refratários e 61,9% responsivos. Dos responsivos, 54 pacientes estavam em segunda remissão completa (85%). Tratamento com quimioterapia em alta dose pré TCTH foi feito em 45 (42,4%) dos pacientes (salvamento). A mobilização das células tronco hematopoiéticas foi realizada com ciclofosfamida 120 mg/kg dividida em dois dias seguido de fator estimulador de colônias de granulócitos (G-CSF) na dose de 6 a 17 mcg/kg em 83 (78%) pacientes. Em 25 pacientes (22%) houve falha de mobilização e a coleta foi realizada por múltiplas punções da medula óssea em centro cirúrgico. O valor mediano de células CD 34 coletadas foi de 2,6 x 106 células CD34/Kg de peso do paciente. Os condicionamentos mais utilizados foram BEAM e CVB, e não se encontrou diferença na sobrevida em relação ao regime empregado (p=0,17). A mediana de enxertia das células transplantadas foi de 12 dias. A sobrevida global após o TCTH pelo método de Kaplan-Meier foi, respectivamente, de 86% e 70% aos 5 e 10 anos. Não influenciaram a sobrevida na análise univariada o sexo, o estadio da doença e a presença de massa tumoral extensa. O principal fator preditivo de melhor sobrevida foi a presença de resposta a quimioterapia pré TCTH (p=0,0095) e hemoglobina maior que 10g/dL ao diagnóstico (p=0,0229). A mortalidade relacionada ao procedimento até o centésimo dia após o TCTH foi de 3,74%, e a principal causa de mortalidade tardia após TCTH foi a recidiva da doença / The study enrolled 106 patients with classic Hodgkin disease (HD) refractory or relapsed after initial treatment who underwent to autologous hematopoietic stem cell transplantation (HSCT) between April 1993 and December 2007. Median age was 28 years and 55 (51,9%) patients were male. Ninety three (87,6%) of patients were white. All patients underwent to conventional chemotherapy protocols prior HSCT. The use of MOPP, ABVD protocols and their associations were used in 97 (91,5%) of the patients. Disease classification was done according to the response to initial treatment and comprised 38,1% refractory and 61,9% responsive patients. In the group of responsive, 54 (85%) patients were in second complete remission. High dose chemotherapy prior HSCT was done as salvage in 45 (42,4%) patients. Stem cell mobilization was done after cyclophosphamide 120mg/kg divided in two days. Granulocyte-colony stimulating factor (G-CSF) 617 mcg/kg was given after cyclophosphamide in 83 (78%) patients. Twenty five (22%) patients failed the mobilization and stem cell harvest was done by bone marrow aspirations. The median number of CD34 collected was 2.6 x 106/L. Preparative regimen mostly used comprised BEAM and CVB and no differences was observed in overall survival (p=0.17). Median time to engraftment was 12 days. Median time of follow-up was 56.4 months. The overall survival (OS) was calculated by the Kaplan-Meier method and was 86% and 70% at 5 and 10 years, respectively. In the univariate analysis, response to initial treatment (p=0.009) and hemoglobin greater than 10g/dL at the time of diagnosis (p=0.02) were factors that influenced better OS. The gender, stage of disease and presence of bulky disease were not significant regarding OS in the univariate analysis. Treatment-related mortality (TRM) in 100-days was 3.74%. The major cause of late mortality was relapse of the disease

Foram analisados 106 pacientes portadores de Linfoma de Hodgkin (LH) com recidiva da doença ou refratários ao tratamento inicial que foram submetidos ao transplante autólogo de células tronco hematopoiéticas (TCTH), na ordem consecutiva de sua realização, entre o mês de abril de 1993 a dezembro de 2007 em um único Centro Brasileiro: o Serviço de Transplante de Medula Óssea da FMUSP. O grupo teve a mediana etária de 28 anos, 55 pacientes (51,9%) eram do sexo masculino e houve predomínio da raça branca (87,6%). A mediana de seguimento clínico foi de 56,4 meses. Todos pacientes foram submetidos no pré TCTH a protocolos de tratamento convencionais, sendo que o uso dos protocolos MOPP, ABVD e sua associação foram utilizados em 97 pacientes (91,5%). Os pacientes foram classificados, de acordo com a resposta ao tratamento utilizado antes do TCTH, sendo 38,1% considerados refratários e 61,9% responsivos. Dos responsivos, 54 pacientes estavam em segunda remissão completa (85%). Tratamento com quimioterapia em alta dose pré TCTH foi feito em 45 (42,4%) dos pacientes (salvamento). A mobilização das células tronco hematopoiéticas foi realizada com ciclofosfamida 120 mg/kg dividida em dois dias seguido de fator estimulador de colônias de granulócitos (G-CSF) na dose de 6 a 17 mcg/kg em 83 (78%) pacientes. Em 25 pacientes (22%) houve falha de mobilização e a coleta foi realizada por múltiplas punções da medula óssea em centro cirúrgico. O valor mediano de células CD 34 coletadas foi de 2,6 x 106 células CD34/Kg de peso do paciente. Os condicionamentos mais utilizados foram BEAM e CVB, e não se encontrou diferença na sobrevida em relação ao regime empregado (p=0,17). A mediana de enxertia das células transplantadas foi de 12 dias. A sobrevida global após o TCTH pelo método de Kaplan-Meier foi, respectivamente, de 86% e 70% aos 5 e 10 anos. Não influenciaram a sobrevida na análise univariada o sexo, o estadio da doença e a presença de massa tumoral extensa. O principal fator preditivo de melhor sobrevida foi a presença de resposta a quimioterapia pré TCTH (p=0,0095) e hemoglobina maior que 10g/dL ao diagnóstico (p=0,0229). A mortalidade relacionada ao procedimento até o centésimo dia após o TCTH foi de 3,74%, e a principal causa de mortalidade tardia após TCTH foi a recidiva da doença / The study enrolled 106 patients with classic Hodgkin disease (HD) refractory or relapsed after initial treatment who underwent to autologous hematopoietic stem cell transplantation (HSCT) between April 1993 and December 2007. Median age was 28 years and 55 (51,9%) patients were male. Ninety three (87,6%) of patients were white. All patients underwent to conventional chemotherapy protocols prior HSCT. The use of MOPP, ABVD protocols and their associations were used in 97 (91,5%) of the patients. Disease classification was done according to the response to initial treatment and comprised 38,1% refractory and 61,9% responsive patients. In the group of responsive, 54 (85%) patients were in second complete remission. High dose chemotherapy prior HSCT was done as salvage in 45 (42,4%) patients. Stem cell mobilization was done after cyclophosphamide 120mg/kg divided in two days. Granulocyte-colony stimulating factor (G-CSF) 617 mcg/kg was given after cyclophosphamide in 83 (78%) patients. Twenty five (22%) patients failed the mobilization and stem cell harvest was done by bone marrow aspirations. The median number of CD34 collected was 2.6 x 106/L. Preparative regimen mostly used comprised BEAM and CVB and no differences was observed in overall survival (p=0.17). Median time to engraftment was 12 days. Median time of follow-up was 56.4 months. The overall survival (OS) was calculated by the Kaplan-Meier method and was 86% and 70% at 5 and 10 years, respectively. In the univariate analysis, response to initial treatment (p=0.009) and hemoglobin greater than 10g/dL at the time of diagnosis (p=0.02) were factors that influenced better OS. The gender, stage of disease and presence of bulky disease were not significant regarding OS in the univariate analysis. Treatment-related mortality (TRM) in 100-days was 3.74%. The major cause of late mortality was relapse of the disease

Diss. (sammanfattning) Uppsala : Univ., 2003. / Härtill 5 uppsatser.